Fill-finish manufacturing is the process of aseptically filling biologics in any form such as solution, powder, or suspension in containers such as vials, syringes, cartridges, ampoules, bottles, and bags. It is an integral part of biopharmaceutical manufacturing after upstream-cell culture & downstream-separation and purification operations.
Key Steps Involved in the Fill-Finish Process Includes:
# Visual inspection.
Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
Factors Influencing Global Growth:-
Technological advancements in fill-finish products, growth of the biopharmaceutical industry, rising adoption of prefilled syringes, and increase in fill-finish outsourcing are the major factors driving this market.
# High Costs Associated With Isolators/Rabs
# Growth of Biomanufacturing in Emerging Markets
# Challenges Associated With Manufacturing Prefilled Syringes
Monetary Growth Expectations, Globally:
According to the Research Study conducted by MarketsandMarkets™: The fill-finish manufacturing market is expected to reach USD 4.47 Billion by 2022 from USD 2.96 Billion in 2017, at a CAGR of 8.6%. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022.
Geographical Growth Scenario:
Europe is expected to dominate the fill-finish manufacturing market in 2017
In 2017, Europe is expected to account for the largest share of the global fill-finish manufacturing market. The large share of the European region is mainly attributed to factors such as the emergence of biosimilar market due to patent expiry of key biologic products, rising incidence of chronic disorders, and increasing focus of major players on enhancing their presence in Europe.
Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
The APAC region is expected to grow at the highest CAGR over the next five years. The growth of the fill-finish manufacturing market in this region is fueled by the overall growth in the biopharmaceutical industry.
Leading Market Players:
# Becton, Dickinson and Company (US)
# West Pharmaceutical Services, Inc. (West Pharmaceutical Services) (US)
# Gerresheimer AG (Gerresheimer) (Germany)
# Robert Bosch GmbH (Robert Bosch) (Germany)
# IMA (Italy)
# OPTIMA (Germany)
# Nipro Medical Corporation (US). and many more…
Product launches remain at the center of the strategic growth initiatives adopted by a majority of key players in the global fill-finish manufacturing market. Companies such as Schott (Germany), Stevanato (Italy), Gerresheimer (Germany), Robert Bosch (Germany), and Becton, Dickinson and Company (US) have been focusing on product launches to enhance their market presence. Players also focused on increasing their presence in high-growth markets through inorganic growth strategies, such as partnerships, collaborations, agreements, expansions, and acquisitions.